India Taking New Look At Price Caps On Essential Drug After Complaints
This article was originally published in PharmAsia News
Executive Summary
India's National Pharmaceutical Pricing Authority has begun requesting from drug makers the costs of making their products considered "essential" to the nation as patients face likely increases as a result.